Evaluation of Long-term Neurodevelopment in Neonatal Encephalopathy by Infant Treadmill
A Randomized Clinical Trial of Infant Treadmill for Long-term Neurodevelopmental Evaluation of Neonatal Encephalopathy
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 201102
- Children Hospital of Fudan University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Gestational age < 33 weeks;
- Correction of gestational age < 3 months;
- It has been diagnosed as hypoxic-ischemic encephalopathy, periventricular intraventricular hemorrhage, periventricular leukomalacia, bilirubin encephalopathy, persistent hypoglycemia and cerebral infarction.
- There was no other therapeutic intervention before entering the study;
- Informed consent is signed by the family.
Exclusion Criteria:
This study is excluded from the study provided that one of the following conditions is met:
- Brain injury caused by central or peripheral infection (cerebrospinal fluid positive / torch test positive / three major conventional culture positive);
- Brain damage caused by convulsion;
- Metabolic brain damage caused by genetic defects;
- Suffering from known severe congenital malformations;
- Definite head trauma during labor or postpartum;
- Peripheral neuromuscular disease or abnormal skeletal system.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: intervention group
Baby treadmill + physical rehabilitation training
|
The newborns who received treadmill intervention were stimulated by running 3 times a week for a total of 10 minutes each time (complete in 5 cycles, 2 minutes per cycle, 2 minutes after the completion of one cycle and rest for 2 minutes to start the next cycle).
Until the completion and completion of the five cycles).
During the remaining four days of each week, other physical rehabilitation training is carried out by the rehabilitator in accordance with the established rehabilitation plan.
The stimulation of running lasted from 3 months of corrected gestational age to being able to walk alone for 3 steps or to correct for 18 months.
Suitable for general physical rehabilitation training of all infants with cerebral palsy.
|
|
Active Comparator: positive control group
Physical rehabilitation training only
|
Suitable for general physical rehabilitation training of all infants with cerebral palsy.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
score from Bayley Scales of Infant and Toddler Development testing
Time Frame: The length of time from birth to the corrected age of 18 months
|
These scores are largely used for screening, helping to identify the need for further observation and intervention, as infants who score very low are at risk for future developmental problems.
|
The length of time from birth to the corrected age of 18 months
|
|
fractional anisotropy(FA)
Time Frame: The length of time from birth to the corrected age of 18 months
|
a variable from Diffusion Tensor Image(DTI)sequence of MRI
|
The length of time from birth to the corrected age of 18 months
|
|
the value of Amplitude of Low Frequency Fluctuation(ALFF)
Time Frame: The length of time from birth to the corrected age of 18 months
|
a variable from resting-blood oxygenation level dependent(BOLD)sequence of MRI
|
The length of time from birth to the corrected age of 18 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Alberta Infant Motor Development Assessment
Time Frame: The length of time from birth to the corrected age of 18 months
|
Neurodevelopmental evaluation scale
|
The length of time from birth to the corrected age of 18 months
|
|
Peabody motor development scale
Time Frame: The length of time from birth to the corrected age of 18 months
|
The Peabody Developmental Motor Scales (PDMS) is composed of six subtests that measure interrelated abilities in early motor development.
It was designed to assess gross and fine motor skills in children from birth through five years of age.
Reflexes (Re), Stationary (St), Locomotion (Lo) , Object Manipulation (Ob), Grasping (Gr), Visual-Motor Integration (Vi).
All of the PDMS-2 subtests contribute to a Total Motor Quotient (TMQ).
|
The length of time from birth to the corrected age of 18 months
|
|
Gross Motor Function Measure Scale
Time Frame: The length of time from birth to the corrected age of 18 months
|
There is a 4-point scoring system for each item on the GMFM.
Specific descriptors for scoring items are detailed in the administration and scoring guidelines.
The GMFM-66 requires a user-friendly computer programme called the Gross Motor Ability Estimator, or GMAE, to enter individual item scores and convert them to an interval level total score.
|
The length of time from birth to the corrected age of 18 months
|
|
the value of regional homogeneity (ReHo)
Time Frame: Corrected age of 18 months
|
a variable from resting-blood oxygenation level dependent(BOLD)sequence of MRI
|
Corrected age of 18 months
|
|
mean diffusion(MD)
Time Frame: The length of time from birth to the corrected age of 18 months
|
a variable from Diffusion Tensor Image(DTI) sequence of MRI
|
The length of time from birth to the corrected age of 18 months
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Publications and helpful links
General Publications
- Vasudevan EV, Patrick SK, Yang JF. Gait Transitions in Human Infants: Coping with Extremes of Treadmill Speed. PLoS One. 2016 Feb 1;11(2):e0148124. doi: 10.1371/journal.pone.0148124. eCollection 2016.
- Teulier C, Lee DK, Ulrich BD. Early gait development in human infants: Plasticity and clinical applications. Dev Psychobiol. 2015 May;57(4):447-58. doi: 10.1002/dev.21291. Epub 2015 Mar 18.
- Siekerman K, Barbu-Roth M, Anderson DI, Donnelly A, Goffinet F, Teulier C. Treadmill stimulation improves newborn stepping. Dev Psychobiol. 2015 Mar;57(2):247-54. doi: 10.1002/dev.21270. Epub 2015 Feb 2.
- de Klerk CC, Johnson MH, Heyes CM, Southgate V. Baby steps: investigating the development of perceptual-motor couplings in infancy. Dev Sci. 2015 Mar;18(2):270-80. doi: 10.1111/desc.12226. Epub 2014 Aug 13.
- Madhavan S, Campbell SK, Campise-Luther R, Gaebler-Spira D, Zawacki L, Clark A, Boynewicz K, Kale D, Bulanda M, Yu J, Sui Y, Zhou XJ. Correlation between fractional anisotropy and motor outcomes in one-year-old infants with periventricular brain injury. J Magn Reson Imaging. 2014 Apr;39(4):949-57. doi: 10.1002/jmri.24256. Epub 2013 Oct 17.
- Angulo-Barroso RM, Tiernan C, Chen LC, Valentin-Gudiol M, Ulrich D. Treadmill training in moderate risk preterm infants promotes stepping quality--results of a small randomised controlled trial. Res Dev Disabil. 2013 Nov;34(11):3629-38. doi: 10.1016/j.ridd.2013.07.037. Epub 2013 Sep 4.
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Ischemia
- Pathologic Processes
- Necrosis
- Cardiovascular Diseases
- Vascular Diseases
- Glucose Metabolism Disorders
- Metabolic Diseases
- Cerebrovascular Disorders
- Central Nervous System Diseases
- Nervous System Diseases
- Immune System Diseases
- Hematologic Diseases
- Infant, Newborn, Diseases
- Signs and Symptoms, Respiratory
- Brain Diseases, Metabolic
- Infarction
- Stroke
- Brain Infarction
- Infant, Premature, Diseases
- Hypoxia
- Hypoxia, Brain
- Hyperbilirubinemia
- Erythroblastosis, Fetal
- Encephalomalacia
- Brain Ischemia
- Hemorrhage
- Hypoglycemia
- Brain Diseases
- Cerebral Infarction
- Hypoxia-Ischemia, Brain
- Leukomalacia, Periventricular
- Kernicterus
Other Study ID Numbers
Other Study ID Numbers
- CHFudanU_NNICU8
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.